Sonnet BioTherapeutics
SONN
SONN
20 hedge funds and large institutions have $997K invested in Sonnet BioTherapeutics in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.
Holders
20
Holders Change
-4
Holders Change %
-16.67%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
7
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
Renaissance Technologies
New York
|
$22K |
2 |
2
Millennium Management
New York
|
$11K |
3 |
3
Citadel Advisors
Miami,
Florida
|
$4K |
4 |
VF
4
Virtu Financial
New York
|
$0 |
5 |
TSS
5
Two Sigma Securities
New York
|
$4K |